✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary Federal rescheduling of marijuana from Schedule I to Schedule III would represent...
In the Mix: 5 More Articles — March 13, 2026
In the Mix — Last 24 HoursMarch 13, 2026. 5 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 Marijuana reclassification may impact drug...
IRS Files First Response to Common Industry 280E Arguments | Harris Beach Murtha – JDSupra
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters The IRS’s response to Section 280E tax deduction arguments directly impacts...
In the Mix: 7 More Articles — March 12, 2026
In the Mix — Last 24 HoursMarch 12, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 IRS Files First Response to...
9th Circuit says Dormant Commerce Clause does not apply to cannabis, sparking circuit split
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters This ruling creates legal uncertainty about interstate cannabis commerce, which could...
IRS disputes cannabis company’s tax argument (Newsletter: March 12, 2026)
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters Cannabis companies’ ongoing tax disputes with the IRS create financial uncertainty...
After win in federal court, Oklahoma medical marijuana operators ramp up fight against state
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustrySafety Clinical Summary Oklahoma medical marijuana operators have achieved a federal court victory and are...
Rescheduling Will Reprice Medical IP, Not Retail Footprints – Business of Cannabis
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchTHCIndustry Clinical Summary Summary Federal rescheduling of cannabis will reshape intellectual property valuations and licensing...
Could President Trump’s marijuana order bring medical cannabis to Tennessee? – News Channel 5
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyMedical CannabisPainNeurology Why This Matters Tennessee clinicians could soon gain the ability to recommend cannabis...
Federal law bars coverage for injured worker’s medical marijuana use, 2nd Circuit says
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyPainSafety Why This Matters Clinicians treating injured workers in states with medical marijuana programs need...